Bu-tuo Xu

472 total citations · 1 hit paper
6 papers, 269 citations indexed

About

Bu-tuo Xu is a scholar working on Physiology, Clinical Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bu-tuo Xu has authored 6 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Clinical Biochemistry and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bu-tuo Xu's work include Diet and metabolism studies (3 papers), Diet, Metabolism, and Disease (2 papers) and Advanced Glycation End Products research (2 papers). Bu-tuo Xu is often cited by papers focused on Diet and metabolism studies (3 papers), Diet, Metabolism, and Disease (2 papers) and Advanced Glycation End Products research (2 papers). Bu-tuo Xu collaborates with scholars based in China and Macao. Bu-tuo Xu's co-authors include Shengrong Wan, Zongzhe Jiang, Yong Xu, Ying An, Yang Long, MA Xiu-mei, Fang‐Yuan Teng, Xiaozhen Tan, Chunxiang Zhang and Huili Xu and has published in prestigious journals such as Oxidative Medicine and Cellular Longevity, Aging and Cardiovascular Diabetology.

In The Last Decade

Bu-tuo Xu

6 papers receiving 264 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction

2023 171 citations Ying An, Bu-tuo Xu et al. Cardiovascular Diabetology profile →

Peers

Bu-tuo Xu

PHYSI

MB

EDM

EPIDE

CCM

Silvia Veses Spain

Hajnalka Lőrincz Hungary

MA Xiu-mei China

Ruili Yin China

Abigail Peairs United States

Jaroslava Trnovská Czechia

Evgeny E. Borisov Russia

Yvo H. A. M. Kusters Netherlands

Shuo Pan China

Silvia Veses Spain

Bu-tuo Xu

76 ×1.1

PHYSI

89 ×1.3

MB

57 ×0.9

EDM

63 ×1.1

EPIDE

39 ×0.9

CCM

Citations per year, relative to Bu-tuo Xu Bu-tuo Xu (= 1×) peers Silvia Veses

Countries citing papers authored by Bu-tuo Xu

Since Specialization

Citations

This map shows the geographic impact of Bu-tuo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bu-tuo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bu-tuo Xu more than expected).

Fields of papers citing papers by Bu-tuo Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bu-tuo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bu-tuo Xu. The network helps show where Bu-tuo Xu may publish in the future.

Co-authorship network of co-authors of Bu-tuo Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Bu-tuo Xu. A scholar is included among the top collaborators of Bu-tuo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bu-tuo Xu. Bu-tuo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Xu, Bu-tuo, Shengrong Wan, Yufeng Xing, et al.. (2025). BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2. Cardiovascular Diabetology. 24(1). 101–101. 9 indexed citations

2.

Xu, Huili, Shengrong Wan, Ying An, et al.. (2024). Targeting cell death in NAFLD: mechanisms and targeted therapies. Cell Death Discovery. 10(1). 399–399. 24 indexed citations

3.

Wan, Shengrong, Fang‐Yuan Teng, Wei Fan, et al.. (2023). BDH1-mediated βOHB metabolism ameliorates diabetic kidney disease by activation of NRF2-mediated antioxidative pathway. Aging. 15(22). 13384–13410. 18 indexed citations

4.

An, Ying, Bu-tuo Xu, Shengrong Wan, et al.. (2023). The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovascular Diabetology. 22(1). 237–237. 171 indexed citations breakdown →

5.

Xu, Bu-tuo, Fang‐Yuan Teng, Shengrong Wan, et al.. (2022). Bdh1 overexpression ameliorates hepatic injury by activation of Nrf2 in a MAFLD mouse model. Cell Death Discovery. 8(1). 49–49. 27 indexed citations

6.

Xu, Bu-tuo, Jing Wu, Yueli Pu, et al.. (2022). Maresin 1 Alleviates Diabetic Kidney Disease via LGR6‐Mediated cAMP‐SOD2‐ROS Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 7177889–7177889. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact